C. Schneider et al.
(5S); elemental analysis calcd (%) for C21H25NO3: C 74.31, H 7.42, N
4.13; found: C 74.12, H 7.29, N 4.20.
250 nm; 10.96 (5R), 13.49 min (5S); elemental analysis calcd (%) for
C20H22N2O5: C 64.85, H 5.99, N 7.56, O 21.60; found: C 64.45, H 5.86, N
7.48, O 21.20.
Compound 5e: 6.5 h; yield 97%; 90% ee; Rf =0.35 (ethyl acetate/petrole-
um ether 1:5); [a]2D2 =+24.8 (c=1.9 in CH2Cl2); 1H NMR (400 MHz,
CDCl3): d=7.35 (s, 1H; ArH), 7.24–7.21 (m, 3H; ArH), 6.87 (dt, J=
15.5, 7.5 Hz, 1H; 3-CH), 6.69 (m, 2H; ArH), 6.45 (m, 2H; ArH), 5.91 (d,
J=15.5 Hz, 1H; 2-CH), 4.39 (dd, J=7.5, 5.5 Hz, 1H; N-CH), 4.18 (q, J=
7.0 Hz, 2H; O-CH2), 3.70 (s, 3H; O-CH3), 2.68 (m, 2H; CH2), 1.28 ppm
(t, J=7.0 Hz, 3H; CH3); 13C NMR (100 MHz, CDCl3): d=166.1, 152.6,
145.3, 144.0, 140.6, 134.8, 130.2, 127.7, 126.6, 124.6, 124.6, 115.0, 114.9,
60.62, 57.51, 55.82, 41.32, 14.36 ppm; IR (film): n˜ =3389, 2982, 2934, 2832,
1712, 1654, 1619, 1511, 1464, 1368, 1312, 1239, 1191, 1094, 1076, 981, 878,
819, 787, 760, 697, 402 cmÀ1; UV/Vis (CHCl3): lmax (loge)=243 (4.027),
308 nm (3.556); HRMS (ESI): m/z: calcd for C40H44Cl2N2O6Na
[2M+Na]+: 741.2470; found: 741.2470; enantiomeric assay: Chiralcel
OD-H, isocratic (hexane/2-propanol 90:10, flow 1.0 mLminÀ1): l=
250 nm; 23.81 (5R), 26.66 min (5S).
Compound 5i: 144 h; yield 88%; 90% ee; Rf =0.25 (ethyl acetate/petro-
leum ether 1:5); [a]2D2 =+14.7 (c=0.4 in CH2Cl2); 1H NMR (400 MHz,
CDCl3): d=7.84–7.81 (m, 4H; ArH), 7.49–7.43 (m, 3H; ArH), 6.95 (dt,
J=15.5, 7.0 Hz, 1H; 3-CH), 6.68 (m, 2H; ArH), 6.51 (m, 2H; ArH), 5.94
(d, J=15.5 Hz, 1H; 2-CH), 4.59 (dd, J=7.0, 5.5 Hz, 1H; N-CH), 4.17 (q,
J=7.0 Hz, 2H; O-CH2), 3.67 (s, 3H; O-CH3), 2.77 (m, 2H; CH2),
1.27 ppm (t, J=7.0 Hz, 3H; CH3); 13C NMR (100 MHz, CDCl3): d=
166.1, 152.4, 144.6, 141.1, 140.5, 133.6, 133.0, 128.8, 128.0, 127.8, 126.3,
125.9, 125.2, 124.5, 124.4, 115.0, 114.9, 60.52, 58.09, 55.82, 41.43,
14.36 ppm; IR (film): n˜ =3399, 3058, 2983, 2933, 2831, 1717, 1654, 1601,
1512, 1463, 1441, 1368, 1309, 1238, 1178, 1126, 1095, 1040, 982, 893, 857,
818, 787, 761, 624, 521, 478 cmÀ1; UV/Vis (CHCl3): lmax (loge)=247
(4.141), 316 nm (3.416); MS (70 eV, EI): m/z (%): 262 (100), 375 (80)
[M]+; enantiomeric assay: Chiralcel OD-H, isocratic (hexane/2-propanol
80:20, flow 1.5 mLminÀ1): l=250 nm; 18.73 (5R), 24.99 min (5S); ele-
mental analysis calcd (%) for C24H25NO3: C 76.77, H 6.71; found: C
76.56, H 6.57.
Compound 5 f: 21 h; yield 97%; 90% ee; Rf =0.30 (ethyl acetate/petrole-
um ether 1:5); [a]2D2 =+42.4 (c=1.6 in CH2Cl2); 1H NMR (400 MHz,
CDCl3): d=7.41–7.36 (m, 1H; ArH), 7.20–7.12 (m, 3H; ArH), 6.95 (dt,
J=15.5, 7.5 Hz, 1H; 3-CH), 6.68 (m, 2H; ArH), 6.40 (m, 2H; ArH), 5.93
(d, J=15.5 Hz, 1H; 2-CH), 4.62 (dd, J=9.0, 5.0 Hz, 1H; N-CH), 4.18 (q,
J=7.0 Hz, 2H; O-CH2), 3.68 (s, 3H; O-CH3), 2.62 (m, 2H; 4-CH2), 2.43
(s, 3H; ArCH3), 1.27 ppm (t, J=7.0 Hz, 3H; CH3); 13C NMR (100 MHz,
CDCl3): d=166.2, 152.2, 145.0, 141.2, 140.6, 134.8, 127.2, 126.8, 125.3,
124.3, 114.9, 114.6, 60.55, 55.83, 53.94, 39.75, 19.25, 14.28 ppm; IR (film):
n˜ =3393, 2928, 2854, 2832, 1712, 1651, 1620, 1512, 1462, 1384, 1368, 1237,
1162, 1111, 1092, 1040, 981, 819, 782, 756, 727, 627, 552, 482 cmÀ1; UV/
Vis (CHCl3): lmax (loge)=244 (4.060), 309 nm (3.541); MS (14 eV, EI):
m/z (%): 226 (100), 340 (80) [M]+; enantiomeric assay: Chiralcel OD-H,
isocratic (hexane/2-propanol 90:10, flow 1.0 mLminÀ1): l=250 nm; 14.76
(5R), 19.84 min (5S); elemental analysis calcd (%) for C21H25NO3: C
74.31, H 7.42, N 4.13; found: C 74.45, H 7.52, N 4.15.
Compound 5j: 96 h; yield 90%; 92% ee; Rf =0.30 (ethyl acetate/petrole-
um ether 1:5); [a]2D2 =+6.6 (c=1.1 in CH2Cl2); 1H NMR (300 MHz,
CDCl3): d=7.29 (dd, J=1.5, 1.5 Hz, 1H; ArH), 7.28–7.23 (m, 1H; ArH),
6.84 (dt, J=15.5, 7.5 Hz, 1H; 3-CH), 6.68 (m, 2H; CH), 6.48 (m, 2H;
ArH), 6.26 (dd, J=1.5, 0.5 Hz, 1H; ArH), 5.82 (dt, J=15.5, 1.5 Hz, 1H;
2-CH), 4.39 (t, J=6.5 Hz, 1H; N-CH), 4.10 (q, J=7.0 Hz, 2H; O-CH2),
3.65 (s, 3H; O-CH3), 2.62 (m, 2H; CH2), 1.20 ppm (t, J=7.0 Hz, 3H;
CH3); 13C NMR (100 MHz, CDCl3): d=166.2, 152.6, 144.5, 143.6, 140.9,
139.7, 127.2, 124.4, 115.3, 114.9, 108.9, 60.53, 55.84, 50.21, 39.13,
14.38 ppm; IR (film): n˜ =3399, 2929, 2854, 2832, 1719, 1654, 1512, 1464,
1441, 1368, 1312, 1243, 1206, 1165, 1096, 1041, 984, 874, 786, 600 cmÀ1
;
UV/Vis (CHCl3): lmax (loge)=244 (4.275), 289 nm (3.751); HRMS (ESI):
m/z: calcd for C18H22NO4 [M+H]+: 316.1543; found: 316.1545; enantio-
meric assay: Chiralcel OD-H, isocratic (hexane/2-propanol 95:5, flow
0.5 mLminÀ1): l=250 nm; 62.00 (5R), 66.67 min (5S).
Compound 5g: 6 h; yield 97%; 85% ee; Rf =0.25 (ethyl acetate/petrole-
um ether 1:5); [a]2D2 =+179.8 (c=2.2 in CH2Cl2); 1H NMR (300 MHz,
CDCl3): d=7.56 (dd, J=7.5, 1.5 Hz, 1H; ArH); 7.40 (dd, J=7.5, 1.5 Hz,
1H; ArH); 7.24 (td, J=7.5, 1.5 Hz, 1H; ArH), 7.11 (td, J=7.5, 1.5 Hz,
1H; ArH), 6.98 (ddd, J=15.5, 7.5, 6.5 Hz, 1H; CH), 6.68 (m, 2H; ArH),
6.38 (m, 2H; ArH), 5.91 (d, J=15.5 Hz, 1H; CH), 4.83 (dd, J=8.5,
4.0 Hz, 1H; N-CH), 4.19 (q, J=7.0 Hz, 2H; O-CH2), 3.90 (s, 1H; NH),
3.68 (s, 3H; O-CH3), 2.79 (dddd, J=15.0, 6.5, 4.0, 1.5 Hz, 1H; CHH),
2.50 (dddd, J=15.0, 8.5, 7.5, 1.0 Hz, 1H; CHH), 1.28 ppm (t, J=7.0 Hz,
3H; CH3); 13C NMR (100 MHz, CDCl3): d=166.2, 152.4, 144.8, 140.6,
132.8, 130.0, 128.6, 127.5, 124.5, 123.1, 114.9, 114.7, 60.57, 56.58, 55.58,
39.37, 14.37 ppm; IR (film): n˜ =3389, 2982, 2934, 2832, 1712, 1654, 1619,
1511, 1464, 1368, 1312, 1239, 1191, 1094, 1076, 981, 878, 819, 787, 760,
697, 402 cmÀ1; UV/Vis (CHCl3): lmax (loge)=243 (4.367), 309 nm (3.540);
MS (ESI): m/z (%): 404/406 (100) [M+H]+, 426/428 (20) [M+Na]+;
enantiomeric assay: Chiralcel AD-H, isocratic (hexane/2-propanol 80:20,
flow 0.5 mLminÀ1): l=250 nm; 13.70 min (5R), 15.67 min (5S); elemental
analysis calcd (%) for C20H22BrNO3: C 59.42, H 5.48, N 3.46; found: C
59.46, H 5.76, N 3.56.
Compound 5k: 14 h; yield 97%; 89% ee; Rf =0.40 (ethyl acetate/petrole-
um ether 1:5); [a]2D2 =À51.0 (c=0.5 in CH2Cl2); 1H NMR (300 MHz,
CDCl3): d=7.32 (dd, J=2.0 Hz, J=1.0 Hz, 1H; ArH), 6.89 (dt, J=15.5,
7.5 Hz, 1H; 3-CH), 6.75 (m, 2H; ArH), 6.58 (m, 2H; ArH), 6.28 (dd, J=
3.5, 2.0 Hz, 1H; ArH), 6.16 (d, J=3.5 Hz, 1H; ArH), 5.89 (dt, J=15.5,
1.5 Hz, 1H; 2-CH), 4.57 (t, J=6.5 Hz, 1H; N-CH), 4.17 (q, J=7.0 Hz,
2H; O-CH2), 3.73 (s, 3H; O-CH3), 2.62 (td, J=6.5, 1.5 Hz, 2H; 4-CH2),
1.28 ppm (t, J=7.0 Hz, 3H; CH3); 13C NMR (100 MHz, CDCl3): d=
166.3, 154.9, 152.9, 144.2, 141.9, 140.5, 124.4, 115.6, 114.9, 110.4, 106.8,
60.51, 55.81, 52.25, 37.48, 14.38 ppm; IR (film): n˜ =3373, 2982, 2935, 2832,
1715, 1656, 1620, 1513, 1441, 1368, 1238, 1164, 1119, 1095, 1070, 1039,
982, 914, 883, 739, 598, 522; UV/Vis (CHCl3): lmax (loge)=244 (4.162),
306 nm (3.470); HRMS (ESI): m/z: calcd for C36H43N2O8 [2M+H]+:
631.3014; found: 631.3018; enantiomeric assay: Chiralcel AD-H, isocratic
(hexane/2-propanol 80:20, flow 1.0 mLminÀ1): l=250 nm; 9.07 (5S),
14.81 min (5R).
Compound 5l: 72 h; yield 95%; 84% ee; Rf =0.30 (ethyl acetate/petrole-
um ether 1:5); [a]2D2 =À11.7 (c=0.9 in CH2Cl2); 1H NMR (300 MHz,
CDCl3): d=7.29 (dd, J=5.0, 3.0 Hz, 1H; ArH), 7.17–7.12 (m, 1H; ArH),
7.03 (dd, J=5.0, 1.5 Hz, 1H; ArH), 6.90 (dt, J=15.5, 7.5 Hz, 1H; 3-CH),
6.72 (m, 2H; ArH), 6.52 (m, 2H; ArH), 5.90 (dt, J=15.5, 1.5 Hz, 1H; 2-
CH), 4.58 (t, J=6.0 Hz, 1H; N-CH), 4.18 (q, J=7.0 Hz, 2H; O-CH2),
3.72 (s, 3H; O-CH3), 3.70 (s, 1H; NH), 2.77 (ddd, J=7.5, 6.0, 1.5 Hz, 2H;
CH2), 1.28 ppm (t, J=7.0 Hz, 3H; CH3); 13C NMR (75 MHz, CDCl3): d=
166.2, 152.5, 144.6, 144.3, 141.1, 126.5, 126.0, 124.3, 121.2, 115.1, 114.9,
60.50, 55.84, 53.97, 40.07, 14.36 ppm; IR (film): n˜ =3384, 3102, 2981, 2933,
2831, 1814, 1713, 1652, 1618, 1510, 1441, 1367, 1237, 1177, 1117, 1094,
1036, 982, 892, 858, 820, 787, 692, 656, 521 cmÀ1; UV/Vis (CHCl3): lmax
(loge)=244 (4.384), 309 nm (3.728); HRMS (ESI): m/z: calcd for
C36H43N2O6S2 [2M+H]+: 663.2557; found: 663.2562; enantiomeric assay:
Chiralcel OD-H, isocratic (hexane/2-propanol 80:20, flow 0.5 mLminÀ1):
l=250 nm; 30.06 (5R), 33.63 min (5S).
Compound 5h: 48 h; yield 96%; 87% ee; Rf =0.20 (ethyl acetate/petrole-
um ether 1:5); [a]2D2 =+166.7 (c=1.3 in CH2Cl2); 1H NMR (400 MHz,
CDCl3): d=7.95 (dd, J=8.0, 1.0 Hz, 1H; ArH), 7.69 (dd, J=8.0, 1.0 Hz,
1H; ArH), 7.55 (ddd, J=8.0, 7.0, 1.0 Hz, 1H; ArH), 7.40 (ddd, J=8.0,
7.0, 1.0 Hz, 1H; ArH), 6.95 (ddd, J=15.5, 8.0, 7.0 Hz, 1H; 3-CH), 6.65
(m, 2H; ArH), 6.37 (m, 2H; ArH), 5.96 (dt, J=15.5, 1.5 Hz, 1H; 2-CH),
5.14 (dd, J=8.5, 4.5 Hz, 1H; N-CH), 4.18 (q, J=7.0 Hz, 2H; O-CH2),
3.92 (s, 1H; NH), 3.68 (s, 3H; O-CH3), 2.88 (m, 1H; CHH), 2.58 (dddd,
J=15.0, 8.5, 8.0, 1.0 Hz, 1H; CHH), 1.29 ppm (t, J=7.0 Hz, 3H; CH3);
13C NMR (100 MHz, CDCl3): d=166.0, 152.7, 149.1, 143.8, 140.1, 138.6,
133.8, 128.4, 125.2, 124.9, 124.6, 114.9, 114.7, 60.64, 55.79, 53.29, 40.31,
14.37 ppm; IR (film): n˜ =3390, 2983, 2934, 2833, 1711, 1655, 1619, 1511,
1463, 1441, 1351, 1239, 1161, 1095, 1039, 982, 820, 760, 738, 690, 627 cmÀ1
;
UV/Vis (CHCl3): lmax (loge)=247 (4.422), 296 nm (3.967); MS (ESI): m/
z (%): 371 (100) [M+H]+, 393 (95) [M+Na]+; enantiomeric assay: Chir-
alcel AD-H, isocratic (hexane/2-propanol 80:20, flow 1.0 mLminÀ1): l=
2814
ꢂ 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2010, 16, 2806 – 2818